We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Catherine Tyner Joins Novella Clinical

Catherine A. Tyner joins the company as executive director, oversight group management to augment Novella’s service offerings.
News

Human Induced Pluripotent Stem Cell Technology Named Gold Winner

Cellular Dynamics International has been named as the overall Gold winner in The Wall Street Journal 2011 Technology Innovation Awards.
News

IntelliCell BioSciences, Inc. Appoints Jack Schneider to Its Board of Advisors

Media veteran, Jack Schneider joins ten other luminaries on the company's Board of Advisors.
News

Mutagenesis of SP-D Informed by Evolution and Xray Crystallography Enhances Defenses Against Influenza A Virus In Vivo

These studies demonstrate the potential utility of homology modeling and protein structure analysis for engineering effective collectin antivirals as in vivo therapeutics.
News

Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale

Researchers from Biberach University of Applied Sciences demonstrate that crystallization has the potential to be included in downstream processing as a low-cost purification or formulation step.
News

Protein-Protein Interactions in Crystals of the Human Receptor-Type Protein Tyrosine Phosphatase ICA512 Ectodomain

In this article researchers utilise X-ray crystallography to study the structure of the mature ectodomain of ICA512 (ME ICA512) and variants thereof.
News

Biocryst Pharmaceuticals Announces Changes to Its Board of Directors

George B. Abercrombie has been elected to the company's board of directors, effective October 10, 2011.
News

NIH-Funded Researchers Correct Sickle Cell Disease in Adult Mice

Protein could be a target for treating people who have the blood disorder.
News

Update On Development of Factor VIII Biopump

Agreement for the joint development of the Factor VIII Biopump expired on September 30, 2011.
News

UW-Madison to Lead National Effort to Improve Quality, Safety of Processed Potatoes

$3.7 million Specialty Crop Research Initiative grant to support an effort to reduce the amount of acrylamide.
Advertisement